JP2025517737A5 - - Google Patents
Info
- Publication number
- JP2025517737A5 JP2025517737A5 JP2024568258A JP2024568258A JP2025517737A5 JP 2025517737 A5 JP2025517737 A5 JP 2025517737A5 JP 2024568258 A JP2024568258 A JP 2024568258A JP 2024568258 A JP2024568258 A JP 2024568258A JP 2025517737 A5 JP2025517737 A5 JP 2025517737A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- amino acid
- cancer
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/093524 | 2022-05-18 | ||
| CN2022093524 | 2022-05-18 | ||
| PCT/CN2023/094711 WO2023222017A1 (en) | 2022-05-18 | 2023-05-17 | Anti-b7h3 antibody and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517737A JP2025517737A (ja) | 2025-06-10 |
| JP2025517737A5 true JP2025517737A5 (enExample) | 2026-05-20 |
Family
ID=88834684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024568258A Pending JP2025517737A (ja) | 2022-05-18 | 2023-05-17 | 抗ｂ７ｈ３抗体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250313633A1 (enExample) |
| EP (1) | EP4526346A1 (enExample) |
| JP (1) | JP2025517737A (enExample) |
| KR (1) | KR20250011957A (enExample) |
| CN (1) | CN119256010A (enExample) |
| AU (1) | AU2023273853A1 (enExample) |
| CA (1) | CA3253563A1 (enExample) |
| CL (1) | CL2024003486A1 (enExample) |
| IL (1) | IL316510A (enExample) |
| MX (1) | MX2024014232A (enExample) |
| TW (1) | TW202402808A (enExample) |
| WO (1) | WO2023222017A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118829656B (zh) * | 2023-12-01 | 2026-04-24 | 苏州智核生物医药科技有限公司 | B7h3结合多肽及其用途 |
| WO2025157244A1 (zh) * | 2024-01-25 | 2025-07-31 | 山东先声生物制药有限公司 | 抗b7h3抗体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012501751A1 (en) * | 2010-03-04 | 2012-11-12 | Macrogenics Inc | Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| AU2015306621B2 (en) * | 2014-08-27 | 2021-05-06 | Memorial Sloan Kettering Cancer Center | Antibodies, compositions, and uses |
| UA125593C2 (uk) * | 2017-03-31 | 2022-04-27 | Джянгсу Хенгруй Медісін Ко., Лтд. | Антитіло в7-н3, його антигензв'язуючий фрагмент та його медичне застосування |
| KR102732027B1 (ko) * | 2019-07-09 | 2024-11-20 | 주식회사 와이바이오로직스 | B7-h3(cd276)에 특이적으로 결합하는 항체 및 그의 용도 |
| CN112851812B (zh) * | 2020-06-30 | 2021-09-14 | 广州百暨基因科技有限公司 | 抗b7h3抗体及其应用 |
| CN113402610B (zh) * | 2021-06-09 | 2023-02-24 | 英诺湖医药(杭州)有限公司 | 一组b7h3单克隆抗体及其医药用途 |
| CN113336851B (zh) * | 2021-06-30 | 2021-12-24 | 徐州医科大学 | 新型全人源抗人b7h3抗体、包含所述抗体的组合物及其应用 |
-
2023
- 2023-05-17 AU AU2023273853A patent/AU2023273853A1/en active Pending
- 2023-05-17 JP JP2024568258A patent/JP2025517737A/ja active Pending
- 2023-05-17 CN CN202380041130.7A patent/CN119256010A/zh active Pending
- 2023-05-17 WO PCT/CN2023/094711 patent/WO2023222017A1/en not_active Ceased
- 2023-05-17 US US18/866,451 patent/US20250313633A1/en active Pending
- 2023-05-17 CA CA3253563A patent/CA3253563A1/en active Pending
- 2023-05-17 EP EP23806968.6A patent/EP4526346A1/en active Pending
- 2023-05-17 TW TW112118340A patent/TW202402808A/zh unknown
- 2023-05-17 KR KR1020247041775A patent/KR20250011957A/ko active Pending
- 2023-05-17 IL IL316510A patent/IL316510A/en unknown
-
2024
- 2024-11-14 CL CL2024003486A patent/CL2024003486A1/es unknown
- 2024-11-15 MX MX2024014232A patent/MX2024014232A/es unknown